Published in:
01-11-2016 | Highlights
News and views
Author:
Peter Witters
Published in:
Journal of Inherited Metabolic Disease
|
Issue 6/2016
Login to get access
Excerpt
In
The Lancet the interim analysis of a promising trial of lentiviral hematopoietic stem cell gene therapy in early-onset metachromatic leukodystrophy (MLD) shows impressive results (Sessa et al
2016). Its innovative approach opens the path to therapies for lysosomal storage disorder with central nervous system (CNS) involvement. …